{"id":"https://openalex.org/W336620534","doi":null,"title":"Requirement of Src kinases Lyn,Hck and Fgr for BCR-ABL 1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.Hu Y,et al.Nat Genet 2004;36:453-61.PMID:15098032--\u8907\u6570\u306e\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u67d3\u8272\u4f53\u967d\u6027\u75be\u60a3(Ph\u3014+\u3015)\u306e\u306a\u304b\u3067Ph\u3014+\u3015B-ALL\u306b\u7279\u7570\u7684\u306a\u9020\u816b\u760d\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u305d\u306e\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u81e8\u5e8a\u5fdc\u7528\u306b\u8db3\u304c\u304b\u308a\u3092\u3064\u3051\u308b\u8ad6\u6587","display_name":"Requirement of Src kinases Lyn,Hck and Fgr for BCR-ABL 1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.Hu Y,et al.Nat Genet 2004;36:453-61.PMID:15098032--\u8907\u6570\u306e\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u67d3\u8272\u4f53\u967d\u6027\u75be\u60a3(Ph\u3014+\u3015)\u306e\u306a\u304b\u3067Ph\u3014+\u3015B-ALL\u306b\u7279\u7570\u7684\u306a\u9020\u816b\u760d\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u305d\u306e\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u81e8\u5e8a\u5fdc\u7528\u306b\u8db3\u304c\u304b\u308a\u3092\u3064\u3051\u308b\u8ad6\u6587","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W336620534","mag":"336620534"},"language":"ja","primary_location":{"id":"mag:336620534","doi":null,"is_oa":false,"landing_page_url":"https://ci.nii.ac.jp/naid/40006624689","pdf_url":null,"source":{"id":"https://openalex.org/S4306519391","display_name":"Mebio oncology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Mebio oncology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087103261","display_name":"\u96c5\u592b \u4e2d\u5ddd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u96c5\u592b \u4e2d\u5ddd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080196025","display_name":"\u5f8b\u6717 \u9234\u6728","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5f8b\u6717 \u9234\u6728","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.02263365,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"1","issue":"3","first_page":"86","last_page":"88"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.026000000536441803,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/src-kinase","display_name":"Src kinase","score":0.8180000185966492},{"id":"https://openalex.org/keywords/lyn-kinase","display_name":"Lyn kinase","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hck","display_name":"Hck","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fgr","display_name":"Fgr","score":1.0},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.984000027179718},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tumor-initiation","display_name":"tumor initiation","score":0.3479999899864197},{"id":"https://openalex.org/keywords/oncogenic-signaling","display_name":"oncogenic signaling","score":0.48100000619888306},{"id":"https://openalex.org/keywords/leukemogenesis","display_name":"leukemogenesis","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C175818844","wikidata":"https://www.wikidata.org/wiki/Q2463389","display_name":"LYN","level":4,"score":0.8940306901931763},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7742761373519897},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.6168233752250671},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5341222882270813},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5217338800430298},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.494123250246048},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.44737353920936584},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.4316464066505432},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4146532416343689},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.40777507424354553},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3817628026008606},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34892499446868896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33088743686676025},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29774266481399536},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.2888595461845398},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2754887640476227},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.11852312088012695}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:336620534","doi":null,"is_oa":false,"landing_page_url":"https://ci.nii.ac.jp/naid/40006624689","pdf_url":null,"source":{"id":"https://openalex.org/S4306519391","display_name":"Mebio oncology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Mebio oncology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2791841422","https://openalex.org/W2037154482","https://openalex.org/W2023026079","https://openalex.org/W2591899706","https://openalex.org/W98143494","https://openalex.org/W2049852513","https://openalex.org/W7100618505","https://openalex.org/W4233221537","https://openalex.org/W2066878282","https://openalex.org/W2594471258"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}